Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Docosapentaenoic acid (22:5n-3): a review of its biological effects.

Kaur G, Cameron-Smith D, Garg M, Sinclair AJ.

Prog Lipid Res. 2011 Jan;50(1):28-34. doi: 10.1016/j.plipres.2010.07.004. Epub 2010 Jul 23. Review.

PMID:
20655949
2.

Short-term docosapentaenoic acid (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats.

Kaur G, Begg DP, Barr D, Garg M, Cameron-Smith D, Sinclair AJ.

Br J Nutr. 2010 Jan;103(1):32-7. doi: 10.1017/S0007114509991334. Epub 2009 Aug 4.

PMID:
19650956
3.
4.
5.

Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells.

Alessandri JM, Extier A, Langelier B, Perruchot MH, Heberden C, Guesnet P, Lavialle M.

Lipids. 2008 Jan;43(1):19-28. Epub 2007 Oct 3.

PMID:
17912567
6.

Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans.

Linderborg KM, Kaur G, Miller E, Meikle PJ, Larsen AE, Weir JM, Nuora A, Barlow CK, Kallio HP, Cameron-Smith D, Sinclair AJ.

Prostaglandins Leukot Essent Fatty Acids. 2013 Apr;88(4):313-9. doi: 10.1016/j.plefa.2013.01.010. Epub 2013 Feb 21.

PMID:
23433939
7.

Effects of three different highly purified n-3 series highly unsaturated fatty acids on lipid metabolism in C57BL/KsJ-db/db mice.

Gotoh N, Nagao K, Onoda S, Shirouchi B, Furuya K, Nagai T, Mizobe H, Ichioka K, Watanabe H, Yanagita T, Wada S.

J Agric Food Chem. 2009 Nov 25;57(22):11047-54. doi: 10.1021/jf9026553.

PMID:
19848389
8.

Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis.

Gregory MK, Gibson RA, Cook-Johnson RJ, Cleland LG, James MJ.

PLoS One. 2011;6(12):e29662. doi: 10.1371/journal.pone.0029662. Epub 2011 Dec 22.

9.

Comparison of the bioavailability of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in the rat.

Ghasemi Fard S, Linderborg KM, Turchini GM, Sinclair AJ.

Prostaglandins Leukot Essent Fatty Acids. 2014 Jan;90(1):23-6. doi: 10.1016/j.plefa.2013.10.001. Epub 2013 Oct 30.

PMID:
24238887
10.

Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid.

Byelashov OA, Sinclair AJ, Kaur G.

Lipid Technol. 2015 Apr;27(4):79-82.

11.

Bioconversion of Docosapentaenoic Acid in Human Cell Lines, Caco-2, HepG2, and THP-1.

Tian Y, Romanazzi D, Miyashita K, Hosokawa M.

J Oleo Sci. 2016 Dec 1;65(12):1017-1022. Epub 2016 Nov 9.

12.
14.
15.

A modified n-3 fatty acid desaturase gene from Caenorhabditis briggsae produced high proportion of DHA and DPA in transgenic mice.

Zhu G, Chen H, Wu X, Zhou Y, Lu J, Chen H, Deng J.

Transgenic Res. 2008 Aug;17(4):717-25. doi: 10.1007/s11248-008-9171-x. Epub 2008 Mar 6.

PMID:
18322818
16.

Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants.

Lin YH, Llanos A, Mena P, Uauy R, Salem N Jr, Pawlosky RJ.

Am J Clin Nutr. 2010 Aug;92(2):284-93. doi: 10.3945/ajcn.2009.28779. Epub 2010 Jun 9.

17.

Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation.

Akiba S, Murata T, Kitatani K, Sato T.

Biol Pharm Bull. 2000 Nov;23(11):1293-7.

PMID:
11085354
18.

Synthesis of structured lipids containing medium-chain and omega-3 fatty acids.

Hamam F, Shahidi F.

J Agric Food Chem. 2006 Jun 14;54(12):4390-6.

PMID:
16756372
19.

The metabolism and distribution of docosapentaenoic acid (n-6) in rats and rat hepatocytes.

Tam PS, Umeda-Sawada R, Yaguchi T, Akimoto K, Kiso Y, Igarashi O.

Lipids. 2000 Jan;35(1):71-5.

PMID:
10695926
20.

Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells.

BĂ©nistant C, Achard F, Ben Slama S, Lagarde M.

Prostaglandins Leukot Essent Fatty Acids. 1996 Oct;55(4):287-92.

PMID:
8951998

Supplemental Content

Support Center